Related Experiment Video
Updated: Dec 25, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Trends in access to female cancer screening in Brazil, 2007-16
Camila M Passos1,2, Jacqueline B Sales2, Emanuella G Maia2,3
1Department of Medicine and Nursing, Federal University of Viçosa, Viçosa, MG, Brazil, 36570-900.
Background:
This study aims to analyse changes in the prevalence of cervical cancer (CCa) and breast cancer (BCa) screening among women in the Brazilian capitals and Federal District in the last decade (2007-16).
Methods:
Data from the surveillance system of risk and protective factors for chronic diseases through telephone interviews (n = 267 949) were used. Adequate screening consisted of, at least, one Pap test triennially, for women aged between 25 and 64 years, and mammography exam biannually, for women aged between 50 and 69 years. The prevalence of adequate screening was investigated for each type of cancer isolated and combined (women aged between 50 and 64 years). The prevalence of adequate screening was estimated for the total population and according to socioeconomic variables. Linear regression models were used.
Results:
The prevalence of adequate screening test for CCa remained stable, around 82%, while the screening test for BCa increased from 71 to 78% between 2007 and 2016. Higher increases were observed among women with low schooling and from less developed regions. The percentage of adequate screening (considering both types), for women aged between 25 and 69 years, remained stable, close to 78%.
Conclusions:
Screening for BCa increased significantly. Smaller coverage rates are verified among women with low schooling and from less developed regions.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Cancer Prevention
Some...
Current Trends in Nursing II

